OncoGenex Pharmaceuticals, Inc. (OGXI) Posts Q4 Loss of 98c/Share

OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q4 EPS of ($0.98), $0.37 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $1.2 million versus the consensus estimate of $1.86 million.

For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Cineverse Corp (CNVS) Misses Q1 EPS by 20c; Offers Guidance
• Birchtech Corp. (BCHT) Misses Q2 EPS by 7c